These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 27792187

  • 1. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X, Foj L.
    Int J Mol Sci; 2016 Oct 26; 17(11):. PubMed ID: 27792187
    [Abstract] [Full Text] [Related]

  • 2. Novel Biomarkers for Prostate Cancer Detection and Prognosis.
    Filella X, Foj L.
    Adv Exp Med Biol; 2018 Oct 26; 1095():15-39. PubMed ID: 30229547
    [Abstract] [Full Text] [Related]

  • 3. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.
    Cornu JN, Cancel-Tassin G, Egrot C, Gaffory C, Haab F, Cussenot O.
    Prostate; 2013 Feb 15; 73(3):242-9. PubMed ID: 22821767
    [Abstract] [Full Text] [Related]

  • 4. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA, Day JR, Lonigro RJ, Hovelson DH, Siddiqui J, Kunju LP, Dunn RL, Meyer S, Hodge P, Groskopf J, Wei JT, Chinnaiyan AM.
    Eur Urol; 2016 Jul 15; 70(1):45-53. PubMed ID: 25985884
    [Abstract] [Full Text] [Related]

  • 5. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.
    Leyten GH, Hessels D, Jannink SA, Smit FP, de Jong H, Cornel EB, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, van Oort IM, Mulders PF, Hulsbergen-van de Kaa CA, Schalken JA.
    Eur Urol; 2014 Mar 15; 65(3):534-42. PubMed ID: 23201468
    [Abstract] [Full Text] [Related]

  • 6. Urinary Biomarkers for Prostate Cancer.
    Tosoian JJ, Ross AE, Sokoll LJ, Partin AW, Pavlovich CP.
    Urol Clin North Am; 2016 Feb 15; 43(1):17-38. PubMed ID: 26614026
    [Abstract] [Full Text] [Related]

  • 7. Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review.
    Sanguedolce F, Cormio A, Brunelli M, D'Amuri A, Carrieri G, Bufo P, Cormio L.
    Clin Genitourin Cancer; 2016 Apr 15; 14(2):117-21. PubMed ID: 26774207
    [Abstract] [Full Text] [Related]

  • 8. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C, Jung M, Rabenhorst S, Kilic E, Jung K.
    Clin Chem Lab Med; 2015 Jun 15; 53(7):1109-18. PubMed ID: 25720086
    [Abstract] [Full Text] [Related]

  • 9. Prostate-specific antigen and other serum and urine markers in prostate cancer.
    Stephan C, Ralla B, Jung K.
    Biochim Biophys Acta; 2014 Aug 15; 1846(1):99-112. PubMed ID: 24727384
    [Abstract] [Full Text] [Related]

  • 10. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
    Hendriks RJ, van Oort IM, Schalken JA.
    Prostate Cancer Prostatic Dis; 2017 Mar 15; 20(1):12-19. PubMed ID: 27922627
    [Abstract] [Full Text] [Related]

  • 11. Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
    Merdan S, Tomlins SA, Barnett CL, Morgan TM, Montie JE, Wei JT, Denton BT.
    Cancer; 2015 Nov 15; 121(22):4071-9. PubMed ID: 26280815
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.
    Hendriks RJ, Dijkstra S, Jannink SA, Steffens MG, van Oort IM, Mulders PF, Schalken JA.
    Clin Chem Lab Med; 2016 Mar 15; 54(3):483-92. PubMed ID: 26630694
    [Abstract] [Full Text] [Related]

  • 13. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
    Salami SS, Schmidt F, Laxman B, Regan MM, Rickman DS, Scherr D, Bueti G, Siddiqui J, Tomlins SA, Wei JT, Chinnaiyan AM, Rubin MA, Sanda MG.
    Urol Oncol; 2013 Jul 15; 31(5):566-71. PubMed ID: 21600800
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.
    Kulda V, Topolcan O, Kucera R, Kripnerova M, Srbecka K, Hora M, Hes O, Klecka J, Babuska V, Rousarova M, Benson V, Pesta M.
    Anticancer Res; 2016 Sep 15; 36(9):4787-93. PubMed ID: 27630329
    [Abstract] [Full Text] [Related]

  • 15. Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.
    Stephan C, Jung K, Semjonow A, Schulze-Forster K, Cammann H, Hu X, Meyer HA, Bögemann M, Miller K, Friedersdorff F.
    Clin Chem; 2013 Jan 15; 59(1):280-8. PubMed ID: 23213079
    [Abstract] [Full Text] [Related]

  • 16. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
    Kovács GL.
    Magy Onkol; 2014 Dec 15; 58(4):301-9. PubMed ID: 25517448
    [Abstract] [Full Text] [Related]

  • 17. A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.
    Donovan MJ, Noerholm M, Bentink S, Belzer S, Skog J, O'Neill V, Cochran JS, Brown GA.
    Prostate Cancer Prostatic Dis; 2015 Dec 15; 18(4):370-5. PubMed ID: 26345389
    [Abstract] [Full Text] [Related]

  • 18. The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics.
    Mytsyk Y, Nakonechnyi Y, Dosenko V, Kowal P, Pietrus M, Gazdikova K, Labudova M, Caprnda M, Prosecky R, Dragasek J, Kruzliak P, Dats R.
    Clin Biochem; 2023 Jun 15; 116():120-127. PubMed ID: 37121562
    [Abstract] [Full Text] [Related]

  • 19. Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects.
    Schmid M, Hansen J, Chun FK.
    Adv Exp Med Biol; 2015 Jun 15; 867():277-89. PubMed ID: 26530372
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.